Skip to main content

Table 1 The relationship between clinicopathological characteristics, MUST, CT-BC and systemic inflammation in patients with COVID-19 as stratified by CFS

From: The relationship between frailty, nutritional status, co-morbidity, CT-body composition and systemic inflammation in patients with COVID-19

Clinicopathological All (n = 106) Non Frail (CFS ≤ 3)
n = 30 (28.3%)
Frail (CFS > 3)
n = 76 (71.7%)
P valuea
Sex 0.714
 Male 56 (52.8) 15 (50) 41 (53.9)  
 Female 50 (47.2) 15 (50) 35 (46.1)
Age (years) < 0.001
 < 70 35 (33.0) 18 (60.0) 17 (22.4)  
 ≥ 70 71 (67.0) 12 (40.0) 59 (77.6)
Smoking Hx. 0.145
 Yes 68 (64.2) 16 (53.3) 52 (68.4)  
 No 38 (35.8) 14 (47.7) 24 (31.6)
Alcohol excess Hx. 0.229
 Yes 18 (17.0) 3 (10.0) 15 (19.7)  
 No 88 (83.0) 27 (90.0) 61 (80.3)
MUSTb 0.380
 0 53 (57.6) 12 (50.0) 41 (60.3)  
 ≥ 1 39 (42.4) 12 (50.0) 27 (39.7)
Hypertension 0.006
 Yes 47 (44.3) 7 (23.3) 40 (52.6)  
 No 59 (55.7) 23 (76.7) 36 (47.4)
Heart failure 0.211
 Yes 14 (13.2) 2 (6.7) 12 (15.8)  
 No 92 (86.8) 28 (93.3) 64 (84.2)
COPD 0.005
 Yes 22 (20.8) 1 (3.3) 21 (27.6)  
 No 84 (79.2) 29 (96.7) 55 (72.4)
T2DM 0.043
 Yes 33 (31.1) 5 (16.7) 28 (36.4)  
 No 73 (68.9) 25 (83.3) 48 (63.2)
Liver disease 0.270
 Yes 13 (12.3) 2 (6.7) 11 (14.5)  
 No 93 (87.7) 28 (93.3) 65 (85.5)
Chronic renal failure 0.514
 Yes 22 (20.8) 5 (4.7) 17 (22.4)  
 No 84 (79.2) 25 (83.3) 59 (77.6)
Active cancer 0.545
 Yes 17 (16.0) 4 (13.3) 13 (17.1)  
 No 89 (84.0) 26 (86.7) 63 (82.9)
Anaemia 0.065
 Yes 54 (50.9) 11 (36.7) 43 (56.6)  
 No 52 (49.1) 19 (63.3) 33 (43.4)
BMI (kg/m2) 0.492
 ≤ 25 48 (45.3) 12 (40.0) 36 (47.4)  
 > 25 58 (54.7) 18 (60.0) 40 (52.6)
High SFI (cm2/m2) 0.072
 Yes 79 (74.5) 26 (86.7) 53 (69.7)  
 No 27 (25.5) 4 (13.3) 23 (30.3)
High VFA (cm2) 0.965
 Yes 71 (67.0) 20 (66.7) 51 (67.1)  
 No 35 (33.0) 10 (33.3) 25 (32.9)
Low SMI (cm2/m2) 0.610
 Yes 85 (80.2) 25 (83.3) 60 (78.9)  
 No 21 (19.8) 5 (16.7) 16 (21.1)
Low SMD (HU) 0.346
 Yes 84 (79.2) 22 (73.3) 62 (81.6)  
 No 22 (20.8) 8 (26.7) 14 (18.4)
CRP (mg/L) 0.976
 ≤ 150 85 (80.2) 24 (80.0) 61 (80.3)  
 > 150 21 (19.8) 6 (20.0) 15 (19.7)
Albumin (g/L) 0.716
 ≥ 25 86 (81.1) 25 (83.3) 61 (80.3)  
 < 25 20 (18.9) 5 (16.7) 15 (19.7)
NLR 0.003
 < 3 25 (23.6) 11 (36.7) 14 (18.4)  
 3–5 23 (21.7) 10 (33.3) 13 (17.1)
 > 5 58 (54.7) 9 (8.5) 49 (64.5)
mGPS 0.278
 0 20 (18.9) 6 (20.0) 14 (18.4)  
 1 13 (12.3) 7 (23.3) 6 (7.9)
 2 73 (68.9) 17 (56.7) 56 (73.7)
  1. aP value from χ2 analysis
  2. b14 patients had no documented nutritional asessment on admission